Anticancer Therapies – News and Features

Researchers have found a new way to reduce T cell exhaustion even in tumors that are resistant to clinically approved immunotherapies.

A new study has explored why some patients do not respond to cancer immunotherapy, demonstrating that specific gut bacteria can alter therapy responses and immune signaling in mouse models.

A team of engineers has developed a stretchable ultrasonic array capable of serial, non-invasive, three-dimensional imaging of tissues as deep as four centimeters below the surface of human skin, at a spatial resolution of 0.5 millimeters.

Cancer patients who use cannabis to address their symptoms have less pain and sleep better, according to new research. But they also experience another, unexpected, benefit: After a few weeks of sustained use, they seem to think more clearly.

A first-in-human clinical trial has successfully delivered chemotherapy drugs through the blood–brain barrier using ultrasound, with the potential to aid treatment for the deadly brain cancer glioblastoma.

Researchers have developed a new platform to test cardiac side effects of chemotherapy using donated heart tissue from dogs.

A new clinical trial has found that adding pembrolizumab, an immunotherapy drug, to the current standard treatment for advanced biliary tract cancer can significantly improve patient survival.

In this opinion piece, Dr. Gen Li discusses how AI and predictive analytics are transforming oncology clinical trials.

Safer cancer drugs are now one step closer after a new study found the likely reason that some treatments damage the heart.

Scientists reveal that the spatial organization of immune cells in the tumor microenvironment of clear cell renal cell carcinoma predicts patient outcomes.